{
  "metadata": {
    "graph_path": "./logic_graph.png",
    "num_solutions": 8,
    "family_stats": {
      "1": {
        "core": 1,
        "branch": 0
      },
      "2": {
        "core": 1,
        "branch": 0
      },
      "3": {
        "core": 1,
        "branch": 0
      },
      "4": {
        "core": 1,
        "branch": 0
      },
      "5": {
        "core": 1,
        "branch": 3
      }
    }
  },
  "knowledge_base": {
    "rules": [
      {
        "id": "Rule1",
        "formal": "(A10 → A11)",
        "prover9_expression": "(launched_product(research_team, market) -> achieved_sales(research_team, target))",
        "natural": "Whenever the research team launches a product on the market, the research team achieves target sales."
      },
      {
        "id": "Rule2",
        "formal": "(A12 → (A11 → (A7 ∨ (¬G → A6))))",
        "prover9_expression": "(expanded_team(research_team, new_members) -> (achieved_sales(research_team, target) -> (secured_patent(research_team, drug_formula) | (-received_funding(research_team, venture_capital) -> identified_mutation(research_team, genetic_variant)))))",
        "natural": "If the research team expanded the team with new members, then should the research team achieve target sales, it follows that either the research team secured a patent for a drug formula or, given that the research team did not receive funding from venture capital, the research team identified a genetic variant mutation."
      },
      {
        "id": "Rule3",
        "formal": "(A12 ∨ A13)",
        "prover9_expression": "(expanded_team(research_team, new_members) | hired_expert(research_team, specialist))",
        "natural": "Either the research team expanded the team with new members or the research team hired a specialist expert."
      },
      {
        "id": "Rule4",
        "formal": "(A13 → (A11 → (A7 ∨ (¬G → A6))))",
        "prover9_expression": "(hired_expert(research_team, specialist) -> (achieved_sales(research_team, target) -> (secured_patent(research_team, drug_formula) | (-received_funding(research_team, venture_capital) -> identified_mutation(research_team, genetic_variant)))))",
        "natural": "Assuming the research team hired a specialist expert, then if the research team achieved target sales, either the research team secured a patent for a drug formula or, provided the research team did not receive funding from venture capital, the research team identified a genetic variant mutation."
      },
      {
        "id": "Rule5",
        "formal": "(A14 → G)",
        "prover9_expression": "(relocated_lab(research_team, asia_pacific) -> received_funding(research_team, venture_capital))",
        "natural": "In the event that the research team relocated the lab to the Asia Pacific, the research team received funding from venture capital."
      },
      {
        "id": "Rule6",
        "formal": "(A15 → G)",
        "prover9_expression": "(opened_branch(research_team, europe) -> received_funding(research_team, venture_capital))",
        "natural": "If the research team opened a branch in Europe, then the research team received funding from venture capital."
      },
      {
        "id": "Rule7",
        "formal": "(A16 → A14)",
        "prover9_expression": "(established_partnership(research_team, hospital_network) -> relocated_lab(research_team, asia_pacific))",
        "natural": "When the research team established a partnership with a hospital network, the research team relocated the lab to the Asia Pacific."
      },
      {
        "id": "Rule8",
        "formal": "(A17 → A15)",
        "prover9_expression": "(signed_agreement(research_team, biotech_firm) -> opened_branch(research_team, europe))",
        "natural": "Provided that the research team signed an agreement with a biotech firm, the research team opened a branch in Europe."
      },
      {
        "id": "Rule9",
        "formal": "(A18 ∨ (A16 ∨ A17))",
        "prover9_expression": "(faced_regulation(research_team, restrictions) | (established_partnership(research_team, hospital_network) | signed_agreement(research_team, biotech_firm)))",
        "natural": "The research team faced regulation restrictions, or the research team established a partnership with a hospital network, or the research team signed an agreement with a biotech firm."
      },
      {
        "id": "Rule10",
        "formal": "(A2 → (A1 ∨ G))",
        "prover9_expression": "(published_paper(research_team, journal) -> (has_funding(research_team, government_grant) | received_funding(research_team, venture_capital)))",
        "natural": "Whenever the research team published a paper in a journal, then either the research team has funding from a government grant or the research team received funding from venture capital."
      },
      {
        "id": "Rule11",
        "formal": "(A20 → (A19 → ¬A18))",
        "prover9_expression": "(improved_process(research_team, quality) -> (resolved_compliance(research_team, standards) -> -faced_regulation(research_team, restrictions)))",
        "natural": "If the research team improved process quality, then when the research team resolved compliance with standards, it follows that the research team did not face regulation restrictions."
      },
      {
        "id": "Rule12",
        "formal": "(A21 → (A19 → ¬A18))",
        "prover9_expression": "(implemented_changes(research_team, protocol) -> (resolved_compliance(research_team, standards) -> -faced_regulation(research_team, restrictions)))",
        "natural": "Given that the research team implemented protocol changes, then if the research team resolved compliance with standards, the research team did not face regulation restrictions."
      },
      {
        "id": "Rule13",
        "formal": "(A22 → A20)",
        "prover9_expression": "(trained_staff(research_team, techniques) -> improved_process(research_team, quality))",
        "natural": "In case the research team trained staff in techniques, the research team improved process quality."
      },
      {
        "id": "Rule14",
        "formal": "(A22 ∨ A23)",
        "prover9_expression": "(trained_staff(research_team, techniques) | updated_equipment(research_team, instruments))",
        "natural": "The research team trained staff in techniques or the research team updated equipment instruments."
      },
      {
        "id": "Rule15",
        "formal": "(A23 → A21)",
        "prover9_expression": "(updated_equipment(research_team, instruments) -> implemented_changes(research_team, protocol))",
        "natural": "Provided that the research team updated equipment instruments, the research team implemented protocol changes."
      },
      {
        "id": "Rule16",
        "formal": "(A24 → G)",
        "prover9_expression": "(attended_conference(research_team, biomedical_summit) -> received_funding(research_team, venture_capital))",
        "natural": "Should the research team attend a biomedical summit conference, the research team received funding from venture capital."
      },
      {
        "id": "Rule17",
        "formal": "(A25 → G)",
        "prover9_expression": "(presented_findings(research_team, symposium) -> received_funding(research_team, venture_capital))",
        "natural": "If the research team presented findings at a symposium, then the research team received funding from venture capital."
      },
      {
        "id": "Rule18",
        "formal": "(A29 → (A28 → (A27 → (A26 ∨ (A24 ∨ A25)))))",
        "prover9_expression": "(formed_consortium(research_team, partners) -> (increased_funding(research_team, investment) -> (gained_recognition(research_team, community) -> (won_award(research_team, innovation_prize) | (attended_conference(research_team, biomedical_summit) | presented_findings(research_team, symposium))))))",
        "natural": "Provided that the research team formed a consortium with partners, then if the research team increased funding investment, and if the research team gained recognition from the community, then either the research team won an innovation prize award, or the research team attended a biomedical summit conference, or the research team presented findings at a symposium."
      },
      {
        "id": "Rule19",
        "formal": "(A29 ∨ A30)",
        "prover9_expression": "(formed_consortium(research_team, partners) | joined_initiative(research_team, global_health))",
        "natural": "Either the research team formed a consortium with partners or the research team joined a global health initiative."
      },
      {
        "id": "Rule20",
        "formal": "(A3 → A2)",
        "prover9_expression": "(developed_technology(research_team, diagnostic_tool) -> published_paper(research_team, journal))",
        "natural": "If the research team developed diagnostic tool technology, then the research team published a paper in a journal."
      },
      {
        "id": "Rule21",
        "formal": "(A30 → (A28 → (A27 → (A26 ∨ (A24 ∨ A25)))))",
        "prover9_expression": "(joined_initiative(research_team, global_health) -> (increased_funding(research_team, investment) -> (gained_recognition(research_team, community) -> (won_award(research_team, innovation_prize) | (attended_conference(research_team, biomedical_summit) | presented_findings(research_team, symposium))))))",
        "natural": "Assuming the research team joined a global health initiative, then if the research team increased funding investment, and if the research team gained recognition from the community, then either the research team won an innovation prize award, or the research team attended a biomedical summit conference, or the research team presented findings at a symposium."
      },
      {
        "id": "Rule22",
        "formal": "(A31 → A33)",
        "prover9_expression": "(detected_outbreak(research_team, disease) -> issued_alert(research_team, authorities))",
        "natural": "Whenever the research team detected a disease outbreak, the research team issued an alert to authorities."
      },
      {
        "id": "Rule23",
        "formal": "(A31 ∨ A32)",
        "prover9_expression": "(detected_outbreak(research_team, disease) | monitored_spread(research_team, regions))",
        "natural": "Either the research team detected a disease outbreak or the research team monitored spread across regions."
      },
      {
        "id": "Rule24",
        "formal": "(A32 → G)",
        "prover9_expression": "(monitored_spread(research_team, regions) -> received_funding(research_team, venture_capital))",
        "natural": "Under the condition that the research team monitored spread across regions, the research team received funding from venture capital."
      },
      {
        "id": "Rule25",
        "formal": "(A35 → A34)",
        "prover9_expression": "(prevented_epidemic(research_team, population) -> contained_threat(research_team, pathogen))",
        "natural": "In case the research team prevented an epidemic in the population, the research team contained a pathogen threat."
      },
      {
        "id": "Rule26",
        "formal": "(A36 → A35)",
        "prover9_expression": "(protected_communities(research_team, vulnerable_groups) -> prevented_epidemic(research_team, population))",
        "natural": "When the research team protected vulnerable group communities, the research team prevented an epidemic in the population."
      },
      {
        "id": "Rule27",
        "formal": "(A37 → A38)",
        "prover9_expression": "(faced_criticism(research_team, methodology) -> retracted_study(research_team, publication))",
        "natural": "Should the research team face methodology criticism, the research team retracted a study publication."
      },
      {
        "id": "Rule28",
        "formal": "(A37 ∨ (A31 → G))",
        "prover9_expression": "(faced_criticism(research_team, methodology) | (detected_outbreak(research_team, disease) -> received_funding(research_team, venture_capital)))",
        "natural": "The research team faced methodology criticism, or if the research team detected a disease outbreak, then the research team received funding from venture capital."
      },
      {
        "id": "Rule29",
        "formal": "(A38 → A39)",
        "prover9_expression": "(retracted_study(research_team, publication) -> corrected_data(research_team, analysis))",
        "natural": "Provided that the research team retracted a study publication, the research team corrected data analysis."
      },
      {
        "id": "Rule30",
        "formal": "(A39 → ¬A40)",
        "prover9_expression": "(corrected_data(research_team, analysis) -> -validated_results(research_team, replication))",
        "natural": "When the research team corrected data analysis, it is not the case that the research team validated results through replication."
      },
      {
        "id": "Rule31",
        "formal": "(A42 → A43)",
        "prover9_expression": "(published_correction(research_team, erratum) -> acknowledged_error(research_team, team))",
        "natural": "If the research team published a correction erratum, then the research team acknowledged error within the team."
      },
      {
        "id": "Rule32",
        "formal": "(A42 → ¬A43)",
        "prover9_expression": "(published_correction(research_team, erratum) -> -acknowledged_error(research_team, team))",
        "natural": "Provided that the research team published a correction erratum, then it is not the case that the research team acknowledged error within the team."
      },
      {
        "id": "Rule33",
        "formal": "(A44 ∨ (¬(A33 → G) → A34))",
        "prover9_expression": "(lost_funding(research_team, sponsor) | (-(issued_alert(research_team, authorities) -> received_funding(research_team, venture_capital)) -> contained_threat(research_team, pathogen)))",
        "natural": "Either the research team lost funding from a sponsor, or if it is not the case that when the research team issued an alert to authorities then the research team received funding from venture capital, then the research team contained a pathogen threat."
      },
      {
        "id": "Rule34",
        "formal": "(A45 → ¬A44)",
        "prover9_expression": "(secured_grant(research_team, foundation) -> -lost_funding(research_team, sponsor))",
        "natural": "In the event that the research team secured a grant from a foundation, then the research team did not lose funding from a sponsor."
      },
      {
        "id": "Rule35",
        "formal": "(A46 ∨ A47)",
        "prover9_expression": "(renewed_contract(research_team, pharma_company) | extended_project(research_team, timeline))",
        "natural": "Either the research team renewed a contract with a pharma company or the research team extended the project timeline."
      },
      {
        "id": "Rule36",
        "formal": "(A47 → (A33 → G))",
        "prover9_expression": "(extended_project(research_team, timeline) -> (issued_alert(research_team, authorities) -> received_funding(research_team, venture_capital)))",
        "natural": "Provided that the research team extended the project timeline, then if the research team issued an alert to authorities, the research team received funding from venture capital."
      },
      {
        "id": "Rule37",
        "formal": "(A48 → (A46 → (A33 → G)))",
        "prover9_expression": "(scaled_operations(research_team, capacity) -> (renewed_contract(research_team, pharma_company) -> (issued_alert(research_team, authorities) -> received_funding(research_team, venture_capital))))",
        "natural": "When the research team scaled operations capacity, then if the research team renewed a contract with a pharma company, and if the research team issued an alert to authorities, then the research team received funding from venture capital."
      },
      {
        "id": "Rule38",
        "formal": "(A48 ∨ A49)",
        "prover9_expression": "(scaled_operations(research_team, capacity) | optimized_workflow(research_team, efficiency))",
        "natural": "Either the research team scaled operations capacity or the research team optimized workflow efficiency."
      },
      {
        "id": "Rule39",
        "formal": "(A49 → (A46 → (A33 → G)))",
        "prover9_expression": "(optimized_workflow(research_team, efficiency) -> (renewed_contract(research_team, pharma_company) -> (issued_alert(research_team, authorities) -> received_funding(research_team, venture_capital))))",
        "natural": "Provided that the research team optimized workflow efficiency, then if the research team renewed a contract with a pharma company, and if the research team issued an alert to authorities, then the research team received funding from venture capital."
      },
      {
        "id": "Rule40",
        "formal": "(A5 ∨ ¬A4)",
        "prover9_expression": "(has_collaboration(research_team, university_lab) | -discovered_cure(research_team, bacterial_pneumonia))",
        "natural": "Either the research team has collaboration with a university lab or the research team did not discover a cure for bacterial pneumonia."
      },
      {
        "id": "Rule41",
        "formal": "(A9 → A8)",
        "prover9_expression": "(received_approval(research_team, regulatory_agency) -> conducted_trial(research_team, phase_3))",
        "natural": "If the research team received approval from a regulatory agency, then the research team conducted a phase 3 trial."
      },
      {
        "id": "Rule42",
        "formal": "(A9 ∨ A10)",
        "prover9_expression": "(received_approval(research_team, regulatory_agency) | launched_product(research_team, market))",
        "natural": "Either the research team received approval from a regulatory agency or the research team launched a product on the market."
      },
      {
        "id": "Rule43",
        "formal": "(¬(A33 → G) → A36)",
        "prover9_expression": "(-(issued_alert(research_team, authorities) -> received_funding(research_team, venture_capital)) -> protected_communities(research_team, vulnerable_groups))",
        "natural": "Provided that it is not the case that if the research team issued an alert to authorities then the research team received funding from venture capital, then the research team protected vulnerable group communities."
      },
      {
        "id": "Rule44",
        "formal": "(¬(A39 → A40) → A41)",
        "prover9_expression": "(-(corrected_data(research_team, analysis) -> validated_results(research_team, replication)) -> restored_credibility(research_team, peers))",
        "natural": "In case it is not the case that if the research team corrected data analysis then the research team validated results through replication, then the research team restored credibility with peers."
      },
      {
        "id": "Rule45",
        "formal": "(¬(¬(A39 → A40) → ¬A41) → A42)",
        "prover9_expression": "(-(-(corrected_data(research_team, analysis) -> validated_results(research_team, replication)) -> -restored_credibility(research_team, peers)) -> published_correction(research_team, erratum))",
        "natural": "Should it not be the case that if it is not the case that when the research team corrected data analysis then the research team validated results through replication then it is not the case that the research team restored credibility with peers, then the research team published a correction erratum."
      },
      {
        "id": "Rule46",
        "formal": "(¬A3 → A4)",
        "prover9_expression": "(-developed_technology(research_team, diagnostic_tool) -> discovered_cure(research_team, bacterial_pneumonia))",
        "natural": "Provided that the research team did not develop diagnostic tool technology, then the research team discovered a cure for bacterial pneumonia."
      }
    ],
    "facts": [
      {
        "id": "Fact1",
        "formal": "A19",
        "prover9_expression": "resolved_compliance(research_team, standards)",
        "natural": "The research team resolved compliance with standards."
      },
      {
        "id": "Fact2",
        "formal": "A27",
        "prover9_expression": "gained_recognition(research_team, community)",
        "natural": "The research team gained recognition from the community."
      },
      {
        "id": "Fact3",
        "formal": "A28",
        "prover9_expression": "increased_funding(research_team, investment)",
        "natural": "The research team increased funding investment."
      },
      {
        "id": "Fact4",
        "formal": "A45",
        "prover9_expression": "secured_grant(research_team, foundation)",
        "natural": "The research team secured a grant from a foundation."
      },
      {
        "id": "Fact5",
        "formal": "¬A1",
        "prover9_expression": "-has_funding(research_team, government_grant)",
        "natural": "It is not the case that the research team has funding from a government grant."
      },
      {
        "id": "Fact6",
        "formal": "¬A26",
        "prover9_expression": "-won_award(research_team, innovation_prize)",
        "natural": "It is not the case that the research team won an innovation prize award."
      },
      {
        "id": "Fact7",
        "formal": "¬A34",
        "prover9_expression": "-contained_threat(research_team, pathogen)",
        "natural": "The research team did not contain a pathogen threat."
      },
      {
        "id": "Fact8",
        "formal": "¬A5",
        "prover9_expression": "-has_collaboration(research_team, university_lab)",
        "natural": "It is not the case that the research team has collaboration with a university lab."
      },
      {
        "id": "Fact9",
        "formal": "¬A6",
        "prover9_expression": "-identified_mutation(research_team, genetic_variant)",
        "natural": "The research team did not identify a genetic variant mutation."
      },
      {
        "id": "Fact10",
        "formal": "¬A7",
        "prover9_expression": "-secured_patent(research_team, drug_formula)",
        "natural": "The research team did not secure a patent for a drug formula."
      },
      {
        "id": "Fact11",
        "formal": "¬A8",
        "prover9_expression": "-conducted_trial(research_team, phase_3)",
        "natural": "The research team did not conduct a phase 3 trial."
      }
    ]
  },
  "target": {
    "formal": "G",
    "prover9": "G",
    "prover9_expression": "received_funding(research_team, venture_capital)",
    "natural": "The research team received funding from venture capital."
  },
  "solutions": [
    {
      "id": 1,
      "family_id": 1,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DS",
          "premises_used": [
            "(A5 | -A4)",
            "-A5"
          ],
          "conclusion": "-A4",
          "natural": "The research team did not discover a cure for bacterial pneumonia."
        },
        {
          "step_number": 2,
          "rule_applied": "MT",
          "premises_used": [
            "(-A3 -> A4)",
            "-A4"
          ],
          "conclusion": "A3",
          "natural": "The research team developed diagnostic tool technology."
        },
        {
          "step_number": 3,
          "rule_applied": "MP",
          "premises_used": [
            "(A3 -> A2)",
            "A3"
          ],
          "conclusion": "A2",
          "natural": "The research team published a paper in a journal."
        },
        {
          "step_number": 4,
          "rule_applied": "MP",
          "premises_used": [
            "(A2 -> (A1 | G))",
            "A2"
          ],
          "conclusion": "(A1 | G)",
          "natural": "Either the research team has funding from a government grant or the research team received funding from venture capital."
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            "(A1 | G)",
            "-A1"
          ],
          "conclusion": "G",
          "natural": "The research team received funding from venture capital."
        }
      ]
    },
    {
      "id": 2,
      "family_id": 2,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DE",
          "premises_used": [
            "(A12 | A13)",
            "(A12 -> (A11 -> (A7 | (-G -> A6))))",
            "(A13 -> (A11 -> (A7 | (-G -> A6))))"
          ],
          "conclusion": "(A11 -> (A7 | (-G -> A6)))",
          "natural": "Under the condition that the research team achieved target sales, then either the research team secured a patent for a drug formula or, if the research team did not receive funding from venture capital, the research team identified a genetic variant mutation."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            "(A10 -> A11)",
            "(A11 -> (A7 | (-G -> A6)))"
          ],
          "conclusion": "(A10 -> (A7 | (-G -> A6)))",
          "natural": "Provided that the research team launched a product on the market, then either the research team secured a patent for a drug formula or, in case the research team did not receive funding from venture capital, the research team identified a genetic variant mutation."
        },
        {
          "step_number": 3,
          "rule_applied": "CD",
          "premises_used": [
            "(A9 -> A8)",
            "(A10 -> (A7 | (-G -> A6)))",
            "(A9 | A10)"
          ],
          "conclusion": "(A8 | (A7 | (-G -> A6)))",
          "natural": "Either the research team conducted a phase 3 trial, or the research team secured a patent for a drug formula, or if the research team did not receive funding from venture capital, then the research team identified a genetic variant mutation."
        },
        {
          "step_number": 4,
          "rule_applied": "DS",
          "premises_used": [
            "(A8 | (A7 | (-G -> A6)))",
            "-A8"
          ],
          "conclusion": "(A7 | (-G -> A6))",
          "natural": "Either the research team secured a patent for a drug formula or, if the research team did not receive funding from venture capital, then the research team identified a genetic variant mutation."
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            "(A7 | (-G -> A6))",
            "-A7"
          ],
          "conclusion": "(-G -> A6)",
          "natural": "If the research team did not receive funding from venture capital, then the research team identified a genetic variant mutation."
        },
        {
          "step_number": 6,
          "rule_applied": "MT",
          "premises_used": [
            "(-G -> A6)",
            "-A6"
          ],
          "conclusion": "G",
          "natural": "The research team received funding from venture capital."
        }
      ]
    },
    {
      "id": 3,
      "family_id": 3,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "CD",
          "premises_used": [
            "(A22 -> A20)",
            "(A23 -> A21)",
            "(A22 | A23)"
          ],
          "conclusion": "(A20 | A21)",
          "natural": "Either the research team improved process quality or the research team implemented protocol changes."
        },
        {
          "step_number": 2,
          "rule_applied": "DE",
          "premises_used": [
            "(A20 | A21)",
            "(A20 -> (A19 -> -A18))",
            "(A21 -> (A19 -> -A18))"
          ],
          "conclusion": "(A19 -> -A18)",
          "natural": "Under the condition that the research team resolved compliance with standards, then it is not the case that the research team faced regulation restrictions."
        },
        {
          "step_number": 3,
          "rule_applied": "MP",
          "premises_used": [
            "(A19 -> -A18)",
            "A19"
          ],
          "conclusion": "-A18",
          "natural": "The research team did not face regulation restrictions."
        },
        {
          "step_number": 4,
          "rule_applied": "DS",
          "premises_used": [
            "(A18 | (A16 | A17))",
            "-A18"
          ],
          "conclusion": "(A16 | A17)",
          "natural": "Either the research team established a partnership with a hospital network or the research team signed an agreement with a biotech firm."
        },
        {
          "step_number": 5,
          "rule_applied": "CD",
          "premises_used": [
            "(A16 -> A14)",
            "(A17 -> A15)",
            "(A16 | A17)"
          ],
          "conclusion": "(A14 | A15)",
          "natural": "The research team relocated the lab to the Asia Pacific or the research team opened a branch in Europe."
        },
        {
          "step_number": 6,
          "rule_applied": "DE",
          "premises_used": [
            "(A14 | A15)",
            "(A14 -> G)",
            "(A15 -> G)"
          ],
          "conclusion": "G",
          "natural": "The research team received funding from venture capital."
        }
      ]
    },
    {
      "id": 4,
      "family_id": 4,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DE",
          "premises_used": [
            "(A29 | A30)",
            "(A29 -> (A28 -> (A27 -> (A26 | (A24 | A25)))))",
            "(A30 -> (A28 -> (A27 -> (A26 | (A24 | A25)))))"
          ],
          "conclusion": "(A28 -> (A27 -> (A26 | (A24 | A25))))",
          "natural": "When the research team increased funding investment, then if the research team gained recognition from the community, it follows that either the research team won an innovation prize award, or the research team attended a biomedical summit conference, or the research team presented findings at a symposium."
        },
        {
          "step_number": 2,
          "rule_applied": "MP",
          "premises_used": [
            "(A28 -> (A27 -> (A26 | (A24 | A25))))",
            "A28"
          ],
          "conclusion": "(A27 -> (A26 | (A24 | A25)))",
          "natural": "Under the condition that the research team gained recognition from the community, then either the research team won an innovation prize award, or the research team attended a biomedical summit conference, or the research team presented findings at a symposium."
        },
        {
          "step_number": 3,
          "rule_applied": "MP",
          "premises_used": [
            "(A27 -> (A26 | (A24 | A25)))",
            "A27"
          ],
          "conclusion": "(A26 | (A24 | A25))",
          "natural": "The research team won an innovation prize award, or the research team attended a biomedical summit conference, or the research team presented findings at a symposium."
        },
        {
          "step_number": 4,
          "rule_applied": "DS",
          "premises_used": [
            "(A26 | (A24 | A25))",
            "-A26"
          ],
          "conclusion": "(A24 | A25)",
          "natural": "Either the research team attended a biomedical summit conference or the research team presented findings at a symposium."
        },
        {
          "step_number": 5,
          "rule_applied": "DE",
          "premises_used": [
            "(A24 | A25)",
            "(A24 -> G)",
            "(A25 -> G)"
          ],
          "conclusion": "G",
          "natural": "The research team received funding from venture capital."
        }
      ]
    },
    {
      "id": 5,
      "family_id": 5,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(-(A33 -> G) -> A36)",
            "(A36 -> A35)"
          ],
          "conclusion": "(-(A33 -> G) -> A35)",
          "natural": "Under the condition that it is not the case that when the research team issued an alert to authorities then the research team received funding from venture capital, then the research team prevented an epidemic in the population."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            "(-(A33 -> G) -> A35)",
            "(A35 -> A34)"
          ],
          "conclusion": "(-(A33 -> G) -> A34)",
          "natural": "Should it not be the case that if the research team issued an alert to authorities then the research team received funding from venture capital, then the research team contained a pathogen threat."
        },
        {
          "step_number": 3,
          "rule_applied": "MT",
          "premises_used": [
            "(-(A33 -> G) -> A34)",
            "-A34"
          ],
          "conclusion": "(A33 -> G)",
          "natural": "If the research team issued an alert to authorities, then the research team received funding from venture capital."
        },
        {
          "step_number": 4,
          "rule_applied": "HS",
          "premises_used": [
            "(A31 -> A33)",
            "(A33 -> G)"
          ],
          "conclusion": "(A31 -> G)",
          "natural": "Provided that the research team detected a disease outbreak, the research team received funding from venture capital."
        },
        {
          "step_number": 5,
          "rule_applied": "DE",
          "premises_used": [
            "(A31 | A32)",
            "(A31 -> G)",
            "(A32 -> G)"
          ],
          "conclusion": "G",
          "natural": "The research team received funding from venture capital."
        }
      ]
    },
    {
      "id": 6,
      "family_id": 5,
      "path_type": "branch",
      "branch_from": 3,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "RAA",
          "premises_used": [
            "(A42 -> A43)",
            "(A42 -> -A43)"
          ],
          "conclusion": "-A42",
          "natural": "It is not the case that the research team published a correction erratum."
        },
        {
          "step_number": 2,
          "rule_applied": "MT",
          "premises_used": [
            "(-(-(A39 -> A40) -> -A41) -> A42)",
            "-A42"
          ],
          "conclusion": "(-(A39 -> A40) -> -A41)",
          "natural": "If it is not the case that when the research team corrected data analysis then the research team validated results through replication, then it is not the case that the research team restored credibility with peers."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A39 -> A40) -> A41)",
            "(-(A39 -> A40) -> -A41)"
          ],
          "conclusion": "(A39 -> A40)",
          "natural": "Under the condition that the research team corrected data analysis, the research team validated results through replication."
        },
        {
          "step_number": 4,
          "rule_applied": "RAA",
          "premises_used": [
            "(A39 -> A40)",
            "(A39 -> -A40)"
          ],
          "conclusion": "-A39",
          "natural": "The research team did not correct data analysis."
        },
        {
          "step_number": 5,
          "rule_applied": "MT",
          "premises_used": [
            "(A38 -> A39)",
            "-A39"
          ],
          "conclusion": "-A38",
          "natural": "It is not the case that the research team retracted a study publication."
        },
        {
          "step_number": 6,
          "rule_applied": "MT",
          "premises_used": [
            "(A37 -> A38)",
            "-A38"
          ],
          "conclusion": "-A37",
          "natural": "The research team did not face methodology criticism."
        },
        {
          "step_number": 7,
          "rule_applied": "DS",
          "premises_used": [
            "(A37 | (A31 -> G))",
            "-A37"
          ],
          "conclusion": "(A31 -> G)",
          "natural": "Provided that the research team detected a disease outbreak, the research team received funding from venture capital."
        },
        {
          "step_number": 8,
          "rule_applied": "DE",
          "premises_used": [
            "(A31 | A32)",
            "(A31 -> G)",
            "(A32 -> G)"
          ],
          "conclusion": "G",
          "natural": "The research team received funding from venture capital."
        }
      ]
    },
    {
      "id": 7,
      "family_id": 5,
      "path_type": "branch",
      "branch_from": 1,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MP",
          "premises_used": [
            "(A45 -> -A44)",
            "A45"
          ],
          "conclusion": "-A44",
          "natural": "The research team did not lose funding from a sponsor."
        },
        {
          "step_number": 2,
          "rule_applied": "DS",
          "premises_used": [
            "(A44 | (-(A33 -> G) -> A34))",
            "-A44"
          ],
          "conclusion": "(-(A33 -> G) -> A34)",
          "natural": "Should it not be the case that if the research team issued an alert to authorities then the research team received funding from venture capital, then the research team contained a pathogen threat."
        },
        {
          "step_number": 3,
          "rule_applied": "MT",
          "premises_used": [
            "(-(A33 -> G) -> A34)",
            "-A34"
          ],
          "conclusion": "(A33 -> G)",
          "natural": "If the research team issued an alert to authorities, then the research team received funding from venture capital."
        },
        {
          "step_number": 4,
          "rule_applied": "HS",
          "premises_used": [
            "(A31 -> A33)",
            "(A33 -> G)"
          ],
          "conclusion": "(A31 -> G)",
          "natural": "Provided that the research team detected a disease outbreak, the research team received funding from venture capital."
        },
        {
          "step_number": 5,
          "rule_applied": "DE",
          "premises_used": [
            "(A31 | A32)",
            "(A31 -> G)",
            "(A32 -> G)"
          ],
          "conclusion": "G",
          "natural": "The research team received funding from venture capital."
        }
      ]
    },
    {
      "id": 8,
      "family_id": 5,
      "path_type": "branch",
      "branch_from": 2,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DE",
          "premises_used": [
            "(A48 | A49)",
            "(A48 -> (A46 -> (A33 -> G)))",
            "(A49 -> (A46 -> (A33 -> G)))"
          ],
          "conclusion": "(A46 -> (A33 -> G))",
          "natural": "Under the condition that the research team renewed a contract with a pharma company, then if the research team issued an alert to authorities, the research team received funding from venture capital."
        },
        {
          "step_number": 2,
          "rule_applied": "DE",
          "premises_used": [
            "(A46 | A47)",
            "(A46 -> (A33 -> G))",
            "(A47 -> (A33 -> G))"
          ],
          "conclusion": "(A33 -> G)",
          "natural": "If the research team issued an alert to authorities, then the research team received funding from venture capital."
        },
        {
          "step_number": 3,
          "rule_applied": "HS",
          "premises_used": [
            "(A31 -> A33)",
            "(A33 -> G)"
          ],
          "conclusion": "(A31 -> G)",
          "natural": "Provided that the research team detected a disease outbreak, the research team received funding from venture capital."
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            "(A31 | A32)",
            "(A31 -> G)",
            "(A32 -> G)"
          ],
          "conclusion": "G",
          "natural": "The research team received funding from venture capital."
        }
      ]
    }
  ],
  "translations": {
    "domain_theme": "Biomedical Research",
    "atomic_facts": {
      "A1": "has_funding(research_team, government_grant)",
      "A2": "published_paper(research_team, journal)",
      "A3": "developed_technology(research_team, diagnostic_tool)",
      "A4": "discovered_cure(research_team, bacterial_pneumonia)",
      "A5": "has_collaboration(research_team, university_lab)",
      "A6": "identified_mutation(research_team, genetic_variant)",
      "A7": "secured_patent(research_team, drug_formula)",
      "A8": "conducted_trial(research_team, phase_3)",
      "A9": "received_approval(research_team, regulatory_agency)",
      "A10": "launched_product(research_team, market)",
      "A11": "achieved_sales(research_team, target)",
      "A12": "expanded_team(research_team, new_members)",
      "A13": "hired_expert(research_team, specialist)",
      "A14": "relocated_lab(research_team, asia_pacific)",
      "A15": "opened_branch(research_team, europe)",
      "A16": "established_partnership(research_team, hospital_network)",
      "A17": "signed_agreement(research_team, biotech_firm)",
      "A18": "faced_regulation(research_team, restrictions)",
      "A19": "resolved_compliance(research_team, standards)",
      "A20": "improved_process(research_team, quality)",
      "A21": "implemented_changes(research_team, protocol)",
      "A22": "trained_staff(research_team, techniques)",
      "A23": "updated_equipment(research_team, instruments)",
      "A24": "attended_conference(research_team, biomedical_summit)",
      "A25": "presented_findings(research_team, symposium)",
      "A26": "won_award(research_team, innovation_prize)",
      "A27": "gained_recognition(research_team, community)",
      "A28": "increased_funding(research_team, investment)",
      "A29": "formed_consortium(research_team, partners)",
      "A30": "joined_initiative(research_team, global_health)",
      "A31": "detected_outbreak(research_team, disease)",
      "A32": "monitored_spread(research_team, regions)",
      "A33": "issued_alert(research_team, authorities)",
      "A34": "contained_threat(research_team, pathogen)",
      "A35": "prevented_epidemic(research_team, population)",
      "A36": "protected_communities(research_team, vulnerable_groups)",
      "A37": "faced_criticism(research_team, methodology)",
      "A38": "retracted_study(research_team, publication)",
      "A39": "corrected_data(research_team, analysis)",
      "A40": "validated_results(research_team, replication)",
      "A41": "restored_credibility(research_team, peers)",
      "A42": "published_correction(research_team, erratum)",
      "A43": "acknowledged_error(research_team, team)",
      "A44": "lost_funding(research_team, sponsor)",
      "A45": "secured_grant(research_team, foundation)",
      "A46": "renewed_contract(research_team, pharma_company)",
      "A47": "extended_project(research_team, timeline)",
      "A48": "scaled_operations(research_team, capacity)",
      "A49": "optimized_workflow(research_team, efficiency)",
      "G": "received_funding(research_team, venture_capital)"
    },
    "natural_facts": {
      "A1": "The research team has funding from a government grant.",
      "A2": "The research team published a paper in a journal.",
      "A3": "The research team developed diagnostic tool technology.",
      "A4": "The research team discovered a cure for bacterial pneumonia.",
      "A5": "The research team has collaboration with a university lab.",
      "A6": "The research team identified a genetic variant mutation.",
      "A7": "The research team secured a patent for a drug formula.",
      "A8": "The research team conducted a phase 3 trial.",
      "A9": "The research team received approval from a regulatory agency.",
      "A10": "The research team launched a product on the market.",
      "A11": "The research team achieved target sales.",
      "A12": "The research team expanded the team with new members.",
      "A13": "The research team hired a specialist expert.",
      "A14": "The research team relocated the lab to the Asia Pacific.",
      "A15": "The research team opened a branch in Europe.",
      "A16": "The research team established a partnership with a hospital network.",
      "A17": "The research team signed an agreement with a biotech firm.",
      "A18": "The research team faced regulation restrictions.",
      "A19": "The research team resolved compliance with standards.",
      "A20": "The research team improved process quality.",
      "A21": "The research team implemented protocol changes.",
      "A22": "The research team trained staff in techniques.",
      "A23": "The research team updated equipment instruments.",
      "A24": "The research team attended a biomedical summit conference.",
      "A25": "The research team presented findings at a symposium.",
      "A26": "The research team won an innovation prize award.",
      "A27": "The research team gained recognition from the community.",
      "A28": "The research team increased funding investment.",
      "A29": "The research team formed a consortium with partners.",
      "A30": "The research team joined a global health initiative.",
      "A31": "The research team detected a disease outbreak.",
      "A32": "The research team monitored spread across regions.",
      "A33": "The research team issued an alert to authorities.",
      "A34": "The research team contained a pathogen threat.",
      "A35": "The research team prevented an epidemic in the population.",
      "A36": "The research team protected vulnerable group communities.",
      "A37": "The research team faced methodology criticism.",
      "A38": "The research team retracted a study publication.",
      "A39": "The research team corrected data analysis.",
      "A40": "The research team validated results through replication.",
      "A41": "The research team restored credibility with peers.",
      "A42": "The research team published a correction erratum.",
      "A43": "The research team acknowledged error within the team.",
      "A44": "The research team lost funding from a sponsor.",
      "A45": "The research team secured a grant from a foundation.",
      "A46": "The research team renewed a contract with a pharma company.",
      "A47": "The research team extended the project timeline.",
      "A48": "The research team scaled operations capacity.",
      "A49": "The research team optimized workflow efficiency.",
      "G": "The research team received funding from venture capital."
    },
    "prover9_expressions": [
      "(has_funding(research_team, government_grant) | received_funding(research_team, venture_capital))",
      "(launched_product(research_team, market) -> (secured_patent(research_team, drug_formula) | (-received_funding(research_team, venture_capital) -> identified_mutation(research_team, genetic_variant))))",
      "(launched_product(research_team, market) -> achieved_sales(research_team, target))",
      "(achieved_sales(research_team, target) -> (secured_patent(research_team, drug_formula) | (-received_funding(research_team, venture_capital) -> identified_mutation(research_team, genetic_variant))))",
      "(expanded_team(research_team, new_members) -> (achieved_sales(research_team, target) -> (secured_patent(research_team, drug_formula) | (-received_funding(research_team, venture_capital) -> identified_mutation(research_team, genetic_variant)))))",
      "(expanded_team(research_team, new_members) | hired_expert(research_team, specialist))",
      "(hired_expert(research_team, specialist) -> (achieved_sales(research_team, target) -> (secured_patent(research_team, drug_formula) | (-received_funding(research_team, venture_capital) -> identified_mutation(research_team, genetic_variant)))))",
      "(relocated_lab(research_team, asia_pacific) -> received_funding(research_team, venture_capital))",
      "(relocated_lab(research_team, asia_pacific) | opened_branch(research_team, europe))",
      "(opened_branch(research_team, europe) -> received_funding(research_team, venture_capital))",
      "(established_partnership(research_team, hospital_network) -> relocated_lab(research_team, asia_pacific))",
      "(established_partnership(research_team, hospital_network) | signed_agreement(research_team, biotech_firm))",
      "(signed_agreement(research_team, biotech_firm) -> opened_branch(research_team, europe))",
      "(faced_regulation(research_team, restrictions) | (established_partnership(research_team, hospital_network) | signed_agreement(research_team, biotech_firm)))",
      "(resolved_compliance(research_team, standards) -> -faced_regulation(research_team, restrictions))",
      "(published_paper(research_team, journal) -> (has_funding(research_team, government_grant) | received_funding(research_team, venture_capital)))",
      "(improved_process(research_team, quality) -> (resolved_compliance(research_team, standards) -> -faced_regulation(research_team, restrictions)))",
      "(improved_process(research_team, quality) | implemented_changes(research_team, protocol))",
      "(implemented_changes(research_team, protocol) -> (resolved_compliance(research_team, standards) -> -faced_regulation(research_team, restrictions)))",
      "(trained_staff(research_team, techniques) -> improved_process(research_team, quality))",
      "(trained_staff(research_team, techniques) | updated_equipment(research_team, instruments))",
      "(updated_equipment(research_team, instruments) -> implemented_changes(research_team, protocol))",
      "(attended_conference(research_team, biomedical_summit) -> received_funding(research_team, venture_capital))",
      "(attended_conference(research_team, biomedical_summit) | presented_findings(research_team, symposium))",
      "(presented_findings(research_team, symposium) -> received_funding(research_team, venture_capital))",
      "(won_award(research_team, innovation_prize) | (attended_conference(research_team, biomedical_summit) | presented_findings(research_team, symposium)))",
      "(gained_recognition(research_team, community) -> (won_award(research_team, innovation_prize) | (attended_conference(research_team, biomedical_summit) | presented_findings(research_team, symposium))))",
      "(increased_funding(research_team, investment) -> (gained_recognition(research_team, community) -> (won_award(research_team, innovation_prize) | (attended_conference(research_team, biomedical_summit) | presented_findings(research_team, symposium)))))",
      "(formed_consortium(research_team, partners) -> (increased_funding(research_team, investment) -> (gained_recognition(research_team, community) -> (won_award(research_team, innovation_prize) | (attended_conference(research_team, biomedical_summit) | presented_findings(research_team, symposium))))))",
      "(formed_consortium(research_team, partners) | joined_initiative(research_team, global_health))",
      "(developed_technology(research_team, diagnostic_tool) -> published_paper(research_team, journal))",
      "(joined_initiative(research_team, global_health) -> (increased_funding(research_team, investment) -> (gained_recognition(research_team, community) -> (won_award(research_team, innovation_prize) | (attended_conference(research_team, biomedical_summit) | presented_findings(research_team, symposium))))))",
      "(detected_outbreak(research_team, disease) -> issued_alert(research_team, authorities))",
      "(detected_outbreak(research_team, disease) -> received_funding(research_team, venture_capital))",
      "(detected_outbreak(research_team, disease) | monitored_spread(research_team, regions))",
      "(monitored_spread(research_team, regions) -> received_funding(research_team, venture_capital))",
      "(issued_alert(research_team, authorities) -> received_funding(research_team, venture_capital))",
      "(prevented_epidemic(research_team, population) -> contained_threat(research_team, pathogen))",
      "(protected_communities(research_team, vulnerable_groups) -> prevented_epidemic(research_team, population))",
      "(faced_criticism(research_team, methodology) -> retracted_study(research_team, publication))",
      "(faced_criticism(research_team, methodology) | (detected_outbreak(research_team, disease) -> received_funding(research_team, venture_capital)))",
      "(retracted_study(research_team, publication) -> corrected_data(research_team, analysis))",
      "(corrected_data(research_team, analysis) -> validated_results(research_team, replication))",
      "(corrected_data(research_team, analysis) -> -validated_results(research_team, replication))",
      "(published_correction(research_team, erratum) -> acknowledged_error(research_team, team))",
      "(published_correction(research_team, erratum) -> -acknowledged_error(research_team, team))",
      "(lost_funding(research_team, sponsor) | (-(issued_alert(research_team, authorities) -> received_funding(research_team, venture_capital)) -> contained_threat(research_team, pathogen)))",
      "(secured_grant(research_team, foundation) -> -lost_funding(research_team, sponsor))",
      "(renewed_contract(research_team, pharma_company) -> (issued_alert(research_team, authorities) -> received_funding(research_team, venture_capital)))",
      "(renewed_contract(research_team, pharma_company) | extended_project(research_team, timeline))",
      "(extended_project(research_team, timeline) -> (issued_alert(research_team, authorities) -> received_funding(research_team, venture_capital)))",
      "(scaled_operations(research_team, capacity) -> (renewed_contract(research_team, pharma_company) -> (issued_alert(research_team, authorities) -> received_funding(research_team, venture_capital))))",
      "(scaled_operations(research_team, capacity) | optimized_workflow(research_team, efficiency))",
      "(optimized_workflow(research_team, efficiency) -> (renewed_contract(research_team, pharma_company) -> (issued_alert(research_team, authorities) -> received_funding(research_team, venture_capital))))",
      "(has_collaboration(research_team, university_lab) | -discovered_cure(research_team, bacterial_pneumonia))",
      "(secured_patent(research_team, drug_formula) | (-received_funding(research_team, venture_capital) -> identified_mutation(research_team, genetic_variant)))",
      "(conducted_trial(research_team, phase_3) | (secured_patent(research_team, drug_formula) | (-received_funding(research_team, venture_capital) -> identified_mutation(research_team, genetic_variant))))",
      "(received_approval(research_team, regulatory_agency) -> conducted_trial(research_team, phase_3))",
      "(received_approval(research_team, regulatory_agency) | launched_product(research_team, market))",
      "(-(issued_alert(research_team, authorities) -> received_funding(research_team, venture_capital)) -> contained_threat(research_team, pathogen))",
      "(-(issued_alert(research_team, authorities) -> received_funding(research_team, venture_capital)) -> prevented_epidemic(research_team, population))",
      "(-(issued_alert(research_team, authorities) -> received_funding(research_team, venture_capital)) -> protected_communities(research_team, vulnerable_groups))",
      "(-(corrected_data(research_team, analysis) -> validated_results(research_team, replication)) -> restored_credibility(research_team, peers))",
      "(-(corrected_data(research_team, analysis) -> validated_results(research_team, replication)) -> -restored_credibility(research_team, peers))",
      "(-(-(corrected_data(research_team, analysis) -> validated_results(research_team, replication)) -> -restored_credibility(research_team, peers)) -> published_correction(research_team, erratum))",
      "(-developed_technology(research_team, diagnostic_tool) -> discovered_cure(research_team, bacterial_pneumonia))",
      "(-received_funding(research_team, venture_capital) -> identified_mutation(research_team, genetic_variant))",
      "resolved_compliance(research_team, standards)",
      "published_paper(research_team, journal)",
      "gained_recognition(research_team, community)",
      "increased_funding(research_team, investment)",
      "developed_technology(research_team, diagnostic_tool)",
      "secured_grant(research_team, foundation)",
      "received_funding(research_team, venture_capital)",
      "-has_funding(research_team, government_grant)",
      "-faced_regulation(research_team, restrictions)",
      "-won_award(research_team, innovation_prize)",
      "-contained_threat(research_team, pathogen)",
      "-faced_criticism(research_team, methodology)",
      "-retracted_study(research_team, publication)",
      "-corrected_data(research_team, analysis)",
      "-discovered_cure(research_team, bacterial_pneumonia)",
      "-published_correction(research_team, erratum)",
      "-lost_funding(research_team, sponsor)",
      "-has_collaboration(research_team, university_lab)",
      "-identified_mutation(research_team, genetic_variant)",
      "-secured_patent(research_team, drug_formula)",
      "-conducted_trial(research_team, phase_3)"
    ],
    "natural_expressions": [
      "Either the research team has funding from a government grant or the research team received funding from venture capital.",
      "Provided that the research team launched a product on the market, then either the research team secured a patent for a drug formula or, in case the research team did not receive funding from venture capital, the research team identified a genetic variant mutation.",
      "Whenever the research team launches a product on the market, the research team achieves target sales.",
      "Under the condition that the research team achieved target sales, then either the research team secured a patent for a drug formula or, if the research team did not receive funding from venture capital, the research team identified a genetic variant mutation.",
      "If the research team expanded the team with new members, then should the research team achieve target sales, it follows that either the research team secured a patent for a drug formula or, given that the research team did not receive funding from venture capital, the research team identified a genetic variant mutation.",
      "Either the research team expanded the team with new members or the research team hired a specialist expert.",
      "Assuming the research team hired a specialist expert, then if the research team achieved target sales, either the research team secured a patent for a drug formula or, provided the research team did not receive funding from venture capital, the research team identified a genetic variant mutation.",
      "In the event that the research team relocated the lab to the Asia Pacific, the research team received funding from venture capital.",
      "The research team relocated the lab to the Asia Pacific or the research team opened a branch in Europe.",
      "If the research team opened a branch in Europe, then the research team received funding from venture capital.",
      "When the research team established a partnership with a hospital network, the research team relocated the lab to the Asia Pacific.",
      "Either the research team established a partnership with a hospital network or the research team signed an agreement with a biotech firm.",
      "Provided that the research team signed an agreement with a biotech firm, the research team opened a branch in Europe.",
      "The research team faced regulation restrictions, or the research team established a partnership with a hospital network, or the research team signed an agreement with a biotech firm.",
      "Under the condition that the research team resolved compliance with standards, then it is not the case that the research team faced regulation restrictions.",
      "Whenever the research team published a paper in a journal, then either the research team has funding from a government grant or the research team received funding from venture capital.",
      "If the research team improved process quality, then when the research team resolved compliance with standards, it follows that the research team did not face regulation restrictions.",
      "Either the research team improved process quality or the research team implemented protocol changes.",
      "Given that the research team implemented protocol changes, then if the research team resolved compliance with standards, the research team did not face regulation restrictions.",
      "In case the research team trained staff in techniques, the research team improved process quality.",
      "The research team trained staff in techniques or the research team updated equipment instruments.",
      "Provided that the research team updated equipment instruments, the research team implemented protocol changes.",
      "Should the research team attend a biomedical summit conference, the research team received funding from venture capital.",
      "Either the research team attended a biomedical summit conference or the research team presented findings at a symposium.",
      "If the research team presented findings at a symposium, then the research team received funding from venture capital.",
      "The research team won an innovation prize award, or the research team attended a biomedical summit conference, or the research team presented findings at a symposium.",
      "Under the condition that the research team gained recognition from the community, then either the research team won an innovation prize award, or the research team attended a biomedical summit conference, or the research team presented findings at a symposium.",
      "When the research team increased funding investment, then if the research team gained recognition from the community, it follows that either the research team won an innovation prize award, or the research team attended a biomedical summit conference, or the research team presented findings at a symposium.",
      "Provided that the research team formed a consortium with partners, then if the research team increased funding investment, and if the research team gained recognition from the community, then either the research team won an innovation prize award, or the research team attended a biomedical summit conference, or the research team presented findings at a symposium.",
      "Either the research team formed a consortium with partners or the research team joined a global health initiative.",
      "If the research team developed diagnostic tool technology, then the research team published a paper in a journal.",
      "Assuming the research team joined a global health initiative, then if the research team increased funding investment, and if the research team gained recognition from the community, then either the research team won an innovation prize award, or the research team attended a biomedical summit conference, or the research team presented findings at a symposium.",
      "Whenever the research team detected a disease outbreak, the research team issued an alert to authorities.",
      "Provided that the research team detected a disease outbreak, the research team received funding from venture capital.",
      "Either the research team detected a disease outbreak or the research team monitored spread across regions.",
      "Under the condition that the research team monitored spread across regions, the research team received funding from venture capital.",
      "If the research team issued an alert to authorities, then the research team received funding from venture capital.",
      "In case the research team prevented an epidemic in the population, the research team contained a pathogen threat.",
      "When the research team protected vulnerable group communities, the research team prevented an epidemic in the population.",
      "Should the research team face methodology criticism, the research team retracted a study publication.",
      "The research team faced methodology criticism, or if the research team detected a disease outbreak, then the research team received funding from venture capital.",
      "Provided that the research team retracted a study publication, the research team corrected data analysis.",
      "Under the condition that the research team corrected data analysis, the research team validated results through replication.",
      "When the research team corrected data analysis, it is not the case that the research team validated results through replication.",
      "If the research team published a correction erratum, then the research team acknowledged error within the team.",
      "Provided that the research team published a correction erratum, then it is not the case that the research team acknowledged error within the team.",
      "Either the research team lost funding from a sponsor, or if it is not the case that when the research team issued an alert to authorities then the research team received funding from venture capital, then the research team contained a pathogen threat.",
      "In the event that the research team secured a grant from a foundation, then the research team did not lose funding from a sponsor.",
      "Under the condition that the research team renewed a contract with a pharma company, then if the research team issued an alert to authorities, the research team received funding from venture capital.",
      "Either the research team renewed a contract with a pharma company or the research team extended the project timeline.",
      "Provided that the research team extended the project timeline, then if the research team issued an alert to authorities, the research team received funding from venture capital.",
      "When the research team scaled operations capacity, then if the research team renewed a contract with a pharma company, and if the research team issued an alert to authorities, then the research team received funding from venture capital.",
      "Either the research team scaled operations capacity or the research team optimized workflow efficiency.",
      "Provided that the research team optimized workflow efficiency, then if the research team renewed a contract with a pharma company, and if the research team issued an alert to authorities, then the research team received funding from venture capital.",
      "Either the research team has collaboration with a university lab or the research team did not discover a cure for bacterial pneumonia.",
      "Either the research team secured a patent for a drug formula or, if the research team did not receive funding from venture capital, then the research team identified a genetic variant mutation.",
      "Either the research team conducted a phase 3 trial, or the research team secured a patent for a drug formula, or if the research team did not receive funding from venture capital, then the research team identified a genetic variant mutation.",
      "If the research team received approval from a regulatory agency, then the research team conducted a phase 3 trial.",
      "Either the research team received approval from a regulatory agency or the research team launched a product on the market.",
      "Should it not be the case that if the research team issued an alert to authorities then the research team received funding from venture capital, then the research team contained a pathogen threat.",
      "Under the condition that it is not the case that when the research team issued an alert to authorities then the research team received funding from venture capital, then the research team prevented an epidemic in the population.",
      "Provided that it is not the case that if the research team issued an alert to authorities then the research team received funding from venture capital, then the research team protected vulnerable group communities.",
      "In case it is not the case that if the research team corrected data analysis then the research team validated results through replication, then the research team restored credibility with peers.",
      "If it is not the case that when the research team corrected data analysis then the research team validated results through replication, then it is not the case that the research team restored credibility with peers.",
      "Should it not be the case that if it is not the case that when the research team corrected data analysis then the research team validated results through replication then it is not the case that the research team restored credibility with peers, then the research team published a correction erratum.",
      "Provided that the research team did not develop diagnostic tool technology, then the research team discovered a cure for bacterial pneumonia.",
      "If the research team did not receive funding from venture capital, then the research team identified a genetic variant mutation.",
      "The research team resolved compliance with standards.",
      "The research team published a paper in a journal.",
      "The research team gained recognition from the community.",
      "The research team increased funding investment.",
      "The research team developed diagnostic tool technology.",
      "The research team secured a grant from a foundation.",
      "The research team received funding from venture capital.",
      "It is not the case that the research team has funding from a government grant.",
      "The research team did not face regulation restrictions.",
      "It is not the case that the research team won an innovation prize award.",
      "The research team did not contain a pathogen threat.",
      "The research team did not face methodology criticism.",
      "It is not the case that the research team retracted a study publication.",
      "The research team did not correct data analysis.",
      "The research team did not discover a cure for bacterial pneumonia.",
      "It is not the case that the research team published a correction erratum.",
      "The research team did not lose funding from a sponsor.",
      "It is not the case that the research team has collaboration with a university lab.",
      "The research team did not identify a genetic variant mutation.",
      "The research team did not secure a patent for a drug formula.",
      "The research team did not conduct a phase 3 trial."
    ],
    "node_mappings": {
      "(A1 ∨ G)": {
        "formal": "(A1 ∨ G)",
        "prover9": "(A1 | G)",
        "prover9_expression": "(has_funding(research_team, government_grant) | received_funding(research_team, venture_capital))",
        "natural": "Either the research team has funding from a government grant or the research team received funding from venture capital."
      },
      "(A10 → (A7 ∨ (¬G → A6)))": {
        "formal": "(A10 → (A7 ∨ (¬G → A6)))",
        "prover9": "(A10 -> (A7 | (-G -> A6)))",
        "prover9_expression": "(launched_product(research_team, market) -> (secured_patent(research_team, drug_formula) | (-received_funding(research_team, venture_capital) -> identified_mutation(research_team, genetic_variant))))",
        "natural": "Provided that the research team launched a product on the market, then either the research team secured a patent for a drug formula or, in case the research team did not receive funding from venture capital, the research team identified a genetic variant mutation."
      },
      "(A10 → A11)": {
        "formal": "(A10 → A11)",
        "prover9": "(A10 -> A11)",
        "prover9_expression": "(launched_product(research_team, market) -> achieved_sales(research_team, target))",
        "natural": "Whenever the research team launches a product on the market, the research team achieves target sales."
      },
      "(A11 → (A7 ∨ (¬G → A6)))": {
        "formal": "(A11 → (A7 ∨ (¬G → A6)))",
        "prover9": "(A11 -> (A7 | (-G -> A6)))",
        "prover9_expression": "(achieved_sales(research_team, target) -> (secured_patent(research_team, drug_formula) | (-received_funding(research_team, venture_capital) -> identified_mutation(research_team, genetic_variant))))",
        "natural": "Under the condition that the research team achieved target sales, then either the research team secured a patent for a drug formula or, if the research team did not receive funding from venture capital, the research team identified a genetic variant mutation."
      },
      "(A12 → (A11 → (A7 ∨ (¬G → A6))))": {
        "formal": "(A12 → (A11 → (A7 ∨ (¬G → A6))))",
        "prover9": "(A12 -> (A11 -> (A7 | (-G -> A6))))",
        "prover9_expression": "(expanded_team(research_team, new_members) -> (achieved_sales(research_team, target) -> (secured_patent(research_team, drug_formula) | (-received_funding(research_team, venture_capital) -> identified_mutation(research_team, genetic_variant)))))",
        "natural": "If the research team expanded the team with new members, then should the research team achieve target sales, it follows that either the research team secured a patent for a drug formula or, given that the research team did not receive funding from venture capital, the research team identified a genetic variant mutation."
      },
      "(A12 ∨ A13)": {
        "formal": "(A12 ∨ A13)",
        "prover9": "(A12 | A13)",
        "prover9_expression": "(expanded_team(research_team, new_members) | hired_expert(research_team, specialist))",
        "natural": "Either the research team expanded the team with new members or the research team hired a specialist expert."
      },
      "(A13 → (A11 → (A7 ∨ (¬G → A6))))": {
        "formal": "(A13 → (A11 → (A7 ∨ (¬G → A6))))",
        "prover9": "(A13 -> (A11 -> (A7 | (-G -> A6))))",
        "prover9_expression": "(hired_expert(research_team, specialist) -> (achieved_sales(research_team, target) -> (secured_patent(research_team, drug_formula) | (-received_funding(research_team, venture_capital) -> identified_mutation(research_team, genetic_variant)))))",
        "natural": "Assuming the research team hired a specialist expert, then if the research team achieved target sales, either the research team secured a patent for a drug formula or, provided the research team did not receive funding from venture capital, the research team identified a genetic variant mutation."
      },
      "(A14 → G)": {
        "formal": "(A14 → G)",
        "prover9": "(A14 -> G)",
        "prover9_expression": "(relocated_lab(research_team, asia_pacific) -> received_funding(research_team, venture_capital))",
        "natural": "In the event that the research team relocated the lab to the Asia Pacific, the research team received funding from venture capital."
      },
      "(A14 ∨ A15)": {
        "formal": "(A14 ∨ A15)",
        "prover9": "(A14 | A15)",
        "prover9_expression": "(relocated_lab(research_team, asia_pacific) | opened_branch(research_team, europe))",
        "natural": "The research team relocated the lab to the Asia Pacific or the research team opened a branch in Europe."
      },
      "(A15 → G)": {
        "formal": "(A15 → G)",
        "prover9": "(A15 -> G)",
        "prover9_expression": "(opened_branch(research_team, europe) -> received_funding(research_team, venture_capital))",
        "natural": "If the research team opened a branch in Europe, then the research team received funding from venture capital."
      },
      "(A16 → A14)": {
        "formal": "(A16 → A14)",
        "prover9": "(A16 -> A14)",
        "prover9_expression": "(established_partnership(research_team, hospital_network) -> relocated_lab(research_team, asia_pacific))",
        "natural": "When the research team established a partnership with a hospital network, the research team relocated the lab to the Asia Pacific."
      },
      "(A16 ∨ A17)": {
        "formal": "(A16 ∨ A17)",
        "prover9": "(A16 | A17)",
        "prover9_expression": "(established_partnership(research_team, hospital_network) | signed_agreement(research_team, biotech_firm))",
        "natural": "Either the research team established a partnership with a hospital network or the research team signed an agreement with a biotech firm."
      },
      "(A17 → A15)": {
        "formal": "(A17 → A15)",
        "prover9": "(A17 -> A15)",
        "prover9_expression": "(signed_agreement(research_team, biotech_firm) -> opened_branch(research_team, europe))",
        "natural": "Provided that the research team signed an agreement with a biotech firm, the research team opened a branch in Europe."
      },
      "(A18 ∨ (A16 ∨ A17))": {
        "formal": "(A18 ∨ (A16 ∨ A17))",
        "prover9": "(A18 | (A16 | A17))",
        "prover9_expression": "(faced_regulation(research_team, restrictions) | (established_partnership(research_team, hospital_network) | signed_agreement(research_team, biotech_firm)))",
        "natural": "The research team faced regulation restrictions, or the research team established a partnership with a hospital network, or the research team signed an agreement with a biotech firm."
      },
      "(A19 → ¬A18)": {
        "formal": "(A19 → ¬A18)",
        "prover9": "(A19 -> -A18)",
        "prover9_expression": "(resolved_compliance(research_team, standards) -> -faced_regulation(research_team, restrictions))",
        "natural": "Under the condition that the research team resolved compliance with standards, then it is not the case that the research team faced regulation restrictions."
      },
      "(A2 → (A1 ∨ G))": {
        "formal": "(A2 → (A1 ∨ G))",
        "prover9": "(A2 -> (A1 | G))",
        "prover9_expression": "(published_paper(research_team, journal) -> (has_funding(research_team, government_grant) | received_funding(research_team, venture_capital)))",
        "natural": "Whenever the research team published a paper in a journal, then either the research team has funding from a government grant or the research team received funding from venture capital."
      },
      "(A20 → (A19 → ¬A18))": {
        "formal": "(A20 → (A19 → ¬A18))",
        "prover9": "(A20 -> (A19 -> -A18))",
        "prover9_expression": "(improved_process(research_team, quality) -> (resolved_compliance(research_team, standards) -> -faced_regulation(research_team, restrictions)))",
        "natural": "If the research team improved process quality, then when the research team resolved compliance with standards, it follows that the research team did not face regulation restrictions."
      },
      "(A20 ∨ A21)": {
        "formal": "(A20 ∨ A21)",
        "prover9": "(A20 | A21)",
        "prover9_expression": "(improved_process(research_team, quality) | implemented_changes(research_team, protocol))",
        "natural": "Either the research team improved process quality or the research team implemented protocol changes."
      },
      "(A21 → (A19 → ¬A18))": {
        "formal": "(A21 → (A19 → ¬A18))",
        "prover9": "(A21 -> (A19 -> -A18))",
        "prover9_expression": "(implemented_changes(research_team, protocol) -> (resolved_compliance(research_team, standards) -> -faced_regulation(research_team, restrictions)))",
        "natural": "Given that the research team implemented protocol changes, then if the research team resolved compliance with standards, the research team did not face regulation restrictions."
      },
      "(A22 → A20)": {
        "formal": "(A22 → A20)",
        "prover9": "(A22 -> A20)",
        "prover9_expression": "(trained_staff(research_team, techniques) -> improved_process(research_team, quality))",
        "natural": "In case the research team trained staff in techniques, the research team improved process quality."
      },
      "(A22 ∨ A23)": {
        "formal": "(A22 ∨ A23)",
        "prover9": "(A22 | A23)",
        "prover9_expression": "(trained_staff(research_team, techniques) | updated_equipment(research_team, instruments))",
        "natural": "The research team trained staff in techniques or the research team updated equipment instruments."
      },
      "(A23 → A21)": {
        "formal": "(A23 → A21)",
        "prover9": "(A23 -> A21)",
        "prover9_expression": "(updated_equipment(research_team, instruments) -> implemented_changes(research_team, protocol))",
        "natural": "Provided that the research team updated equipment instruments, the research team implemented protocol changes."
      },
      "(A24 → G)": {
        "formal": "(A24 → G)",
        "prover9": "(A24 -> G)",
        "prover9_expression": "(attended_conference(research_team, biomedical_summit) -> received_funding(research_team, venture_capital))",
        "natural": "Should the research team attend a biomedical summit conference, the research team received funding from venture capital."
      },
      "(A24 ∨ A25)": {
        "formal": "(A24 ∨ A25)",
        "prover9": "(A24 | A25)",
        "prover9_expression": "(attended_conference(research_team, biomedical_summit) | presented_findings(research_team, symposium))",
        "natural": "Either the research team attended a biomedical summit conference or the research team presented findings at a symposium."
      },
      "(A25 → G)": {
        "formal": "(A25 → G)",
        "prover9": "(A25 -> G)",
        "prover9_expression": "(presented_findings(research_team, symposium) -> received_funding(research_team, venture_capital))",
        "natural": "If the research team presented findings at a symposium, then the research team received funding from venture capital."
      },
      "(A26 ∨ (A24 ∨ A25))": {
        "formal": "(A26 ∨ (A24 ∨ A25))",
        "prover9": "(A26 | (A24 | A25))",
        "prover9_expression": "(won_award(research_team, innovation_prize) | (attended_conference(research_team, biomedical_summit) | presented_findings(research_team, symposium)))",
        "natural": "The research team won an innovation prize award, or the research team attended a biomedical summit conference, or the research team presented findings at a symposium."
      },
      "(A27 → (A26 ∨ (A24 ∨ A25)))": {
        "formal": "(A27 → (A26 ∨ (A24 ∨ A25)))",
        "prover9": "(A27 -> (A26 | (A24 | A25)))",
        "prover9_expression": "(gained_recognition(research_team, community) -> (won_award(research_team, innovation_prize) | (attended_conference(research_team, biomedical_summit) | presented_findings(research_team, symposium))))",
        "natural": "Under the condition that the research team gained recognition from the community, then either the research team won an innovation prize award, or the research team attended a biomedical summit conference, or the research team presented findings at a symposium."
      },
      "(A28 → (A27 → (A26 ∨ (A24 ∨ A25))))": {
        "formal": "(A28 → (A27 → (A26 ∨ (A24 ∨ A25))))",
        "prover9": "(A28 -> (A27 -> (A26 | (A24 | A25))))",
        "prover9_expression": "(increased_funding(research_team, investment) -> (gained_recognition(research_team, community) -> (won_award(research_team, innovation_prize) | (attended_conference(research_team, biomedical_summit) | presented_findings(research_team, symposium)))))",
        "natural": "When the research team increased funding investment, then if the research team gained recognition from the community, it follows that either the research team won an innovation prize award, or the research team attended a biomedical summit conference, or the research team presented findings at a symposium."
      },
      "(A29 → (A28 → (A27 → (A26 ∨ (A24 ∨ A25)))))": {
        "formal": "(A29 → (A28 → (A27 → (A26 ∨ (A24 ∨ A25)))))",
        "prover9": "(A29 -> (A28 -> (A27 -> (A26 | (A24 | A25)))))",
        "prover9_expression": "(formed_consortium(research_team, partners) -> (increased_funding(research_team, investment) -> (gained_recognition(research_team, community) -> (won_award(research_team, innovation_prize) | (attended_conference(research_team, biomedical_summit) | presented_findings(research_team, symposium))))))",
        "natural": "Provided that the research team formed a consortium with partners, then if the research team increased funding investment, and if the research team gained recognition from the community, then either the research team won an innovation prize award, or the research team attended a biomedical summit conference, or the research team presented findings at a symposium."
      },
      "(A29 ∨ A30)": {
        "formal": "(A29 ∨ A30)",
        "prover9": "(A29 | A30)",
        "prover9_expression": "(formed_consortium(research_team, partners) | joined_initiative(research_team, global_health))",
        "natural": "Either the research team formed a consortium with partners or the research team joined a global health initiative."
      },
      "(A3 → A2)": {
        "formal": "(A3 → A2)",
        "prover9": "(A3 -> A2)",
        "prover9_expression": "(developed_technology(research_team, diagnostic_tool) -> published_paper(research_team, journal))",
        "natural": "If the research team developed diagnostic tool technology, then the research team published a paper in a journal."
      },
      "(A30 → (A28 → (A27 → (A26 ∨ (A24 ∨ A25)))))": {
        "formal": "(A30 → (A28 → (A27 → (A26 ∨ (A24 ∨ A25)))))",
        "prover9": "(A30 -> (A28 -> (A27 -> (A26 | (A24 | A25)))))",
        "prover9_expression": "(joined_initiative(research_team, global_health) -> (increased_funding(research_team, investment) -> (gained_recognition(research_team, community) -> (won_award(research_team, innovation_prize) | (attended_conference(research_team, biomedical_summit) | presented_findings(research_team, symposium))))))",
        "natural": "Assuming the research team joined a global health initiative, then if the research team increased funding investment, and if the research team gained recognition from the community, then either the research team won an innovation prize award, or the research team attended a biomedical summit conference, or the research team presented findings at a symposium."
      },
      "(A31 → A33)": {
        "formal": "(A31 → A33)",
        "prover9": "(A31 -> A33)",
        "prover9_expression": "(detected_outbreak(research_team, disease) -> issued_alert(research_team, authorities))",
        "natural": "Whenever the research team detected a disease outbreak, the research team issued an alert to authorities."
      },
      "(A31 → G)": {
        "formal": "(A31 → G)",
        "prover9": "(A31 -> G)",
        "prover9_expression": "(detected_outbreak(research_team, disease) -> received_funding(research_team, venture_capital))",
        "natural": "Provided that the research team detected a disease outbreak, the research team received funding from venture capital."
      },
      "(A31 ∨ A32)": {
        "formal": "(A31 ∨ A32)",
        "prover9": "(A31 | A32)",
        "prover9_expression": "(detected_outbreak(research_team, disease) | monitored_spread(research_team, regions))",
        "natural": "Either the research team detected a disease outbreak or the research team monitored spread across regions."
      },
      "(A32 → G)": {
        "formal": "(A32 → G)",
        "prover9": "(A32 -> G)",
        "prover9_expression": "(monitored_spread(research_team, regions) -> received_funding(research_team, venture_capital))",
        "natural": "Under the condition that the research team monitored spread across regions, the research team received funding from venture capital."
      },
      "(A33 → G)": {
        "formal": "(A33 → G)",
        "prover9": "(A33 -> G)",
        "prover9_expression": "(issued_alert(research_team, authorities) -> received_funding(research_team, venture_capital))",
        "natural": "If the research team issued an alert to authorities, then the research team received funding from venture capital."
      },
      "(A35 → A34)": {
        "formal": "(A35 → A34)",
        "prover9": "(A35 -> A34)",
        "prover9_expression": "(prevented_epidemic(research_team, population) -> contained_threat(research_team, pathogen))",
        "natural": "In case the research team prevented an epidemic in the population, the research team contained a pathogen threat."
      },
      "(A36 → A35)": {
        "formal": "(A36 → A35)",
        "prover9": "(A36 -> A35)",
        "prover9_expression": "(protected_communities(research_team, vulnerable_groups) -> prevented_epidemic(research_team, population))",
        "natural": "When the research team protected vulnerable group communities, the research team prevented an epidemic in the population."
      },
      "(A37 → A38)": {
        "formal": "(A37 → A38)",
        "prover9": "(A37 -> A38)",
        "prover9_expression": "(faced_criticism(research_team, methodology) -> retracted_study(research_team, publication))",
        "natural": "Should the research team face methodology criticism, the research team retracted a study publication."
      },
      "(A37 ∨ (A31 → G))": {
        "formal": "(A37 ∨ (A31 → G))",
        "prover9": "(A37 | (A31 -> G))",
        "prover9_expression": "(faced_criticism(research_team, methodology) | (detected_outbreak(research_team, disease) -> received_funding(research_team, venture_capital)))",
        "natural": "The research team faced methodology criticism, or if the research team detected a disease outbreak, then the research team received funding from venture capital."
      },
      "(A38 → A39)": {
        "formal": "(A38 → A39)",
        "prover9": "(A38 -> A39)",
        "prover9_expression": "(retracted_study(research_team, publication) -> corrected_data(research_team, analysis))",
        "natural": "Provided that the research team retracted a study publication, the research team corrected data analysis."
      },
      "(A39 → A40)": {
        "formal": "(A39 → A40)",
        "prover9": "(A39 -> A40)",
        "prover9_expression": "(corrected_data(research_team, analysis) -> validated_results(research_team, replication))",
        "natural": "Under the condition that the research team corrected data analysis, the research team validated results through replication."
      },
      "(A39 → ¬A40)": {
        "formal": "(A39 → ¬A40)",
        "prover9": "(A39 -> -A40)",
        "prover9_expression": "(corrected_data(research_team, analysis) -> -validated_results(research_team, replication))",
        "natural": "When the research team corrected data analysis, it is not the case that the research team validated results through replication."
      },
      "(A42 → A43)": {
        "formal": "(A42 → A43)",
        "prover9": "(A42 -> A43)",
        "prover9_expression": "(published_correction(research_team, erratum) -> acknowledged_error(research_team, team))",
        "natural": "If the research team published a correction erratum, then the research team acknowledged error within the team."
      },
      "(A42 → ¬A43)": {
        "formal": "(A42 → ¬A43)",
        "prover9": "(A42 -> -A43)",
        "prover9_expression": "(published_correction(research_team, erratum) -> -acknowledged_error(research_team, team))",
        "natural": "Provided that the research team published a correction erratum, then it is not the case that the research team acknowledged error within the team."
      },
      "(A44 ∨ (¬(A33 → G) → A34))": {
        "formal": "(A44 ∨ (¬(A33 → G) → A34))",
        "prover9": "(A44 | (-(A33 -> G) -> A34))",
        "prover9_expression": "(lost_funding(research_team, sponsor) | (-(issued_alert(research_team, authorities) -> received_funding(research_team, venture_capital)) -> contained_threat(research_team, pathogen)))",
        "natural": "Either the research team lost funding from a sponsor, or if it is not the case that when the research team issued an alert to authorities then the research team received funding from venture capital, then the research team contained a pathogen threat."
      },
      "(A45 → ¬A44)": {
        "formal": "(A45 → ¬A44)",
        "prover9": "(A45 -> -A44)",
        "prover9_expression": "(secured_grant(research_team, foundation) -> -lost_funding(research_team, sponsor))",
        "natural": "In the event that the research team secured a grant from a foundation, then the research team did not lose funding from a sponsor."
      },
      "(A46 → (A33 → G))": {
        "formal": "(A46 → (A33 → G))",
        "prover9": "(A46 -> (A33 -> G))",
        "prover9_expression": "(renewed_contract(research_team, pharma_company) -> (issued_alert(research_team, authorities) -> received_funding(research_team, venture_capital)))",
        "natural": "Under the condition that the research team renewed a contract with a pharma company, then if the research team issued an alert to authorities, the research team received funding from venture capital."
      },
      "(A46 ∨ A47)": {
        "formal": "(A46 ∨ A47)",
        "prover9": "(A46 | A47)",
        "prover9_expression": "(renewed_contract(research_team, pharma_company) | extended_project(research_team, timeline))",
        "natural": "Either the research team renewed a contract with a pharma company or the research team extended the project timeline."
      },
      "(A47 → (A33 → G))": {
        "formal": "(A47 → (A33 → G))",
        "prover9": "(A47 -> (A33 -> G))",
        "prover9_expression": "(extended_project(research_team, timeline) -> (issued_alert(research_team, authorities) -> received_funding(research_team, venture_capital)))",
        "natural": "Provided that the research team extended the project timeline, then if the research team issued an alert to authorities, the research team received funding from venture capital."
      },
      "(A48 → (A46 → (A33 → G)))": {
        "formal": "(A48 → (A46 → (A33 → G)))",
        "prover9": "(A48 -> (A46 -> (A33 -> G)))",
        "prover9_expression": "(scaled_operations(research_team, capacity) -> (renewed_contract(research_team, pharma_company) -> (issued_alert(research_team, authorities) -> received_funding(research_team, venture_capital))))",
        "natural": "When the research team scaled operations capacity, then if the research team renewed a contract with a pharma company, and if the research team issued an alert to authorities, then the research team received funding from venture capital."
      },
      "(A48 ∨ A49)": {
        "formal": "(A48 ∨ A49)",
        "prover9": "(A48 | A49)",
        "prover9_expression": "(scaled_operations(research_team, capacity) | optimized_workflow(research_team, efficiency))",
        "natural": "Either the research team scaled operations capacity or the research team optimized workflow efficiency."
      },
      "(A49 → (A46 → (A33 → G)))": {
        "formal": "(A49 → (A46 → (A33 → G)))",
        "prover9": "(A49 -> (A46 -> (A33 -> G)))",
        "prover9_expression": "(optimized_workflow(research_team, efficiency) -> (renewed_contract(research_team, pharma_company) -> (issued_alert(research_team, authorities) -> received_funding(research_team, venture_capital))))",
        "natural": "Provided that the research team optimized workflow efficiency, then if the research team renewed a contract with a pharma company, and if the research team issued an alert to authorities, then the research team received funding from venture capital."
      },
      "(A5 ∨ ¬A4)": {
        "formal": "(A5 ∨ ¬A4)",
        "prover9": "(A5 | -A4)",
        "prover9_expression": "(has_collaboration(research_team, university_lab) | -discovered_cure(research_team, bacterial_pneumonia))",
        "natural": "Either the research team has collaboration with a university lab or the research team did not discover a cure for bacterial pneumonia."
      },
      "(A7 ∨ (¬G → A6))": {
        "formal": "(A7 ∨ (¬G → A6))",
        "prover9": "(A7 | (-G -> A6))",
        "prover9_expression": "(secured_patent(research_team, drug_formula) | (-received_funding(research_team, venture_capital) -> identified_mutation(research_team, genetic_variant)))",
        "natural": "Either the research team secured a patent for a drug formula or, if the research team did not receive funding from venture capital, then the research team identified a genetic variant mutation."
      },
      "(A8 ∨ (A7 ∨ (¬G → A6)))": {
        "formal": "(A8 ∨ (A7 ∨ (¬G → A6)))",
        "prover9": "(A8 | (A7 | (-G -> A6)))",
        "prover9_expression": "(conducted_trial(research_team, phase_3) | (secured_patent(research_team, drug_formula) | (-received_funding(research_team, venture_capital) -> identified_mutation(research_team, genetic_variant))))",
        "natural": "Either the research team conducted a phase 3 trial, or the research team secured a patent for a drug formula, or if the research team did not receive funding from venture capital, then the research team identified a genetic variant mutation."
      },
      "(A9 → A8)": {
        "formal": "(A9 → A8)",
        "prover9": "(A9 -> A8)",
        "prover9_expression": "(received_approval(research_team, regulatory_agency) -> conducted_trial(research_team, phase_3))",
        "natural": "If the research team received approval from a regulatory agency, then the research team conducted a phase 3 trial."
      },
      "(A9 ∨ A10)": {
        "formal": "(A9 ∨ A10)",
        "prover9": "(A9 | A10)",
        "prover9_expression": "(received_approval(research_team, regulatory_agency) | launched_product(research_team, market))",
        "natural": "Either the research team received approval from a regulatory agency or the research team launched a product on the market."
      },
      "(¬(A33 → G) → A34)": {
        "formal": "(¬(A33 → G) → A34)",
        "prover9": "(-(A33 -> G) -> A34)",
        "prover9_expression": "(-(issued_alert(research_team, authorities) -> received_funding(research_team, venture_capital)) -> contained_threat(research_team, pathogen))",
        "natural": "Should it not be the case that if the research team issued an alert to authorities then the research team received funding from venture capital, then the research team contained a pathogen threat."
      },
      "(¬(A33 → G) → A35)": {
        "formal": "(¬(A33 → G) → A35)",
        "prover9": "(-(A33 -> G) -> A35)",
        "prover9_expression": "(-(issued_alert(research_team, authorities) -> received_funding(research_team, venture_capital)) -> prevented_epidemic(research_team, population))",
        "natural": "Under the condition that it is not the case that when the research team issued an alert to authorities then the research team received funding from venture capital, then the research team prevented an epidemic in the population."
      },
      "(¬(A33 → G) → A36)": {
        "formal": "(¬(A33 → G) → A36)",
        "prover9": "(-(A33 -> G) -> A36)",
        "prover9_expression": "(-(issued_alert(research_team, authorities) -> received_funding(research_team, venture_capital)) -> protected_communities(research_team, vulnerable_groups))",
        "natural": "Provided that it is not the case that if the research team issued an alert to authorities then the research team received funding from venture capital, then the research team protected vulnerable group communities."
      },
      "(¬(A39 → A40) → A41)": {
        "formal": "(¬(A39 → A40) → A41)",
        "prover9": "(-(A39 -> A40) -> A41)",
        "prover9_expression": "(-(corrected_data(research_team, analysis) -> validated_results(research_team, replication)) -> restored_credibility(research_team, peers))",
        "natural": "In case it is not the case that if the research team corrected data analysis then the research team validated results through replication, then the research team restored credibility with peers."
      },
      "(¬(A39 → A40) → ¬A41)": {
        "formal": "(¬(A39 → A40) → ¬A41)",
        "prover9": "(-(A39 -> A40) -> -A41)",
        "prover9_expression": "(-(corrected_data(research_team, analysis) -> validated_results(research_team, replication)) -> -restored_credibility(research_team, peers))",
        "natural": "If it is not the case that when the research team corrected data analysis then the research team validated results through replication, then it is not the case that the research team restored credibility with peers."
      },
      "(¬(¬(A39 → A40) → ¬A41) → A42)": {
        "formal": "(¬(¬(A39 → A40) → ¬A41) → A42)",
        "prover9": "(-(-(A39 -> A40) -> -A41) -> A42)",
        "prover9_expression": "(-(-(corrected_data(research_team, analysis) -> validated_results(research_team, replication)) -> -restored_credibility(research_team, peers)) -> published_correction(research_team, erratum))",
        "natural": "Should it not be the case that if it is not the case that when the research team corrected data analysis then the research team validated results through replication then it is not the case that the research team restored credibility with peers, then the research team published a correction erratum."
      },
      "(¬A3 → A4)": {
        "formal": "(¬A3 → A4)",
        "prover9": "(-A3 -> A4)",
        "prover9_expression": "(-developed_technology(research_team, diagnostic_tool) -> discovered_cure(research_team, bacterial_pneumonia))",
        "natural": "Provided that the research team did not develop diagnostic tool technology, then the research team discovered a cure for bacterial pneumonia."
      },
      "(¬G → A6)": {
        "formal": "(¬G → A6)",
        "prover9": "(-G -> A6)",
        "prover9_expression": "(-received_funding(research_team, venture_capital) -> identified_mutation(research_team, genetic_variant))",
        "natural": "If the research team did not receive funding from venture capital, then the research team identified a genetic variant mutation."
      },
      "A19": {
        "formal": "A19",
        "prover9": "A19",
        "prover9_expression": "resolved_compliance(research_team, standards)",
        "natural": "The research team resolved compliance with standards."
      },
      "A2": {
        "formal": "A2",
        "prover9": "A2",
        "prover9_expression": "published_paper(research_team, journal)",
        "natural": "The research team published a paper in a journal."
      },
      "A27": {
        "formal": "A27",
        "prover9": "A27",
        "prover9_expression": "gained_recognition(research_team, community)",
        "natural": "The research team gained recognition from the community."
      },
      "A28": {
        "formal": "A28",
        "prover9": "A28",
        "prover9_expression": "increased_funding(research_team, investment)",
        "natural": "The research team increased funding investment."
      },
      "A3": {
        "formal": "A3",
        "prover9": "A3",
        "prover9_expression": "developed_technology(research_team, diagnostic_tool)",
        "natural": "The research team developed diagnostic tool technology."
      },
      "A45": {
        "formal": "A45",
        "prover9": "A45",
        "prover9_expression": "secured_grant(research_team, foundation)",
        "natural": "The research team secured a grant from a foundation."
      },
      "G": {
        "formal": "G",
        "prover9": "G",
        "prover9_expression": "received_funding(research_team, venture_capital)",
        "natural": "The research team received funding from venture capital."
      },
      "¬A1": {
        "formal": "¬A1",
        "prover9": "-A1",
        "prover9_expression": "-has_funding(research_team, government_grant)",
        "natural": "It is not the case that the research team has funding from a government grant."
      },
      "¬A18": {
        "formal": "¬A18",
        "prover9": "-A18",
        "prover9_expression": "-faced_regulation(research_team, restrictions)",
        "natural": "The research team did not face regulation restrictions."
      },
      "¬A26": {
        "formal": "¬A26",
        "prover9": "-A26",
        "prover9_expression": "-won_award(research_team, innovation_prize)",
        "natural": "It is not the case that the research team won an innovation prize award."
      },
      "¬A34": {
        "formal": "¬A34",
        "prover9": "-A34",
        "prover9_expression": "-contained_threat(research_team, pathogen)",
        "natural": "The research team did not contain a pathogen threat."
      },
      "¬A37": {
        "formal": "¬A37",
        "prover9": "-A37",
        "prover9_expression": "-faced_criticism(research_team, methodology)",
        "natural": "The research team did not face methodology criticism."
      },
      "¬A38": {
        "formal": "¬A38",
        "prover9": "-A38",
        "prover9_expression": "-retracted_study(research_team, publication)",
        "natural": "It is not the case that the research team retracted a study publication."
      },
      "¬A39": {
        "formal": "¬A39",
        "prover9": "-A39",
        "prover9_expression": "-corrected_data(research_team, analysis)",
        "natural": "The research team did not correct data analysis."
      },
      "¬A4": {
        "formal": "¬A4",
        "prover9": "-A4",
        "prover9_expression": "-discovered_cure(research_team, bacterial_pneumonia)",
        "natural": "The research team did not discover a cure for bacterial pneumonia."
      },
      "¬A42": {
        "formal": "¬A42",
        "prover9": "-A42",
        "prover9_expression": "-published_correction(research_team, erratum)",
        "natural": "It is not the case that the research team published a correction erratum."
      },
      "¬A44": {
        "formal": "¬A44",
        "prover9": "-A44",
        "prover9_expression": "-lost_funding(research_team, sponsor)",
        "natural": "The research team did not lose funding from a sponsor."
      },
      "¬A5": {
        "formal": "¬A5",
        "prover9": "-A5",
        "prover9_expression": "-has_collaboration(research_team, university_lab)",
        "natural": "It is not the case that the research team has collaboration with a university lab."
      },
      "¬A6": {
        "formal": "¬A6",
        "prover9": "-A6",
        "prover9_expression": "-identified_mutation(research_team, genetic_variant)",
        "natural": "The research team did not identify a genetic variant mutation."
      },
      "¬A7": {
        "formal": "¬A7",
        "prover9": "-A7",
        "prover9_expression": "-secured_patent(research_team, drug_formula)",
        "natural": "The research team did not secure a patent for a drug formula."
      },
      "¬A8": {
        "formal": "¬A8",
        "prover9": "-A8",
        "prover9_expression": "-conducted_trial(research_team, phase_3)",
        "natural": "The research team did not conduct a phase 3 trial."
      }
    }
  }
}